Dougal McClean

4.4k citations

51 papers · 3.2k · 2 hit papers · h-index 24

Impact in

Surgery top 0.5%
- Coronary Interventions and Diagnostics
- Peripheral Artery Disease Management
Cardiology and Cardiovascular Medicine top 2%
- Cardiac Valve Diseases and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases

Papers in

Surgery 41
- Coronary Interventions and Diagnostics 40
- Peripheral Artery Disease Management 2
Cardiology and Cardiovascular Medicine 12
- Cardiac Valve Diseases and Treatments 5
- Acute Myocardial Infarction Research 4
- Antiplatelet Therapy and Cardiovascular Diseases 2

Co-authors: Patrick W. Serruys (26 shared papers)Yoshinobu Onuma (21 shared papers)Dariusz Dudek (17 shared papers)Stephan Windecker (21 shared papers)Bernard Chevalier (19 shared papers)Jacques Koolen (21 shared papers)Robert Whitbourn (21 shared papers)John A. Ormiston (22 shared papers)
Journals: EuroIntervention (9 papers)Journal of the American College of Cardiology (8 papers)JACC: Cardiovascular Interventions (7 papers)Circulation Cardiovascular Interventions (2 papers)Circulation (2 papers)
Partner nations: New Zealand Netherlands Australia

In The Last Decade

Dougal McClean

48 papers receiving 3.1k citations

Dougal McClean's Hit Papers

align trajectories log scale

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial 2016 · 365 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 The Lancet
2011 Journal of the American College of Cardiology

Peers

Countries citing papers authored by Dougal McClean

Since Specialization

Citations

This map shows the geographic impact of Dougal McClean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dougal McClean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dougal McClean more than expected).

Fields of papers citing papers by Dougal McClean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dougal McClean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dougal McClean. The network helps show where Dougal McClean may publish in the future.

Co-authors

The 25 scholars most cited alongside Dougal McClean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dougal McClean Line = papers co-authored together Dougal McClean links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis Journal of the American College of Cardiology ·Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Pieter C. Smits, Jacques Koolen, Bernard Chevalier, Bernard De Bruyne, Leif Thuesen, Dougal McClean, Robert‐Jan van Geuns, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Krishnankutty Sudhir, Héctor M. García‐García, John A. Ormiston Hit paper breakdown →	2011	424
2	Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial The Lancet ·Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi, Ángel Cequier, Didier Carrié, Jan J. Piek, Ad J. van Boven, Marcello Dominici, Dariusz Dudek, Dougal McClean, Steffen Helqvist, Michael Haude, Sebastian Reith, Manuel Almeida, Gianluca Campo, Andrés Íñiguez, Manel Sabaté, Stephan Windecker, Yoshinobu Onuma Hit paper breakdown →	2016	365
3	Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis Circulation ·Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston, Bernard De Bruyne, Evelyn Regar, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel‐Hébert, Richard Rapoza, Héctor M. García‐García	2010	248
4	Botulinum toxin A in the hemiplegia upper limb: a double‐blind trial Developmental Medicine & Child Neurology ·I. S. Corry, A P. Cosgroce, E G Walsh, Dougal McClean, H. Kerr Graham	1997	223
5	Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months EuroIntervention ·Patrick W. Serruys, Yoshinobu Onuma, Héctor M. García‐García, Takashi Muramatsu, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Richard Rapoza, John A. Ormiston	2014	182
6	First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold Circulation Cardiovascular Interventions ·John A. Ormiston, Patrick W. Serruys, Yoshinobu Onuma, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Richard Rapoza, Héctor M. García‐García	2012	165
7	Local Drug Delivery via a Coronary Stent With Programmable Release Pharmacokinetics Circulation ·Ariel Finkelstein, Dougal McClean, Saibal Kar, Kaname Takizawa, Kiron Varghese, Namjin Baek, Kinam Park, Michael C. Fishbein, Raj Makkar, Frank Litvack, Neal Eigler	2003	149
8	The Effect of Variable Dose and Release Kinetics on Neointimal Hyperplasia Using a Novel Paclitaxel-Eluting Stent Platform Journal of the American College of Cardiology ·Patrick W. Serruys, Georgios Sianos, Alexandre Abizaid, Jiro Aoki, Peter den Heijer, Hans Bonnier, Pieter C. Smits, Dougal McClean, Stefan Verheye, Jorge Belardi, José A. Condado, Michel Pieper, Louise Gambone, Marco Bressers, Janette Symons, Eduardo Sousa, Frank Litvack	2005	140
9	A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis Journal of the American College of Cardiology ·Patrick W. Serruys, John Ormiston, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Evald Høj Christiansen, Bernard Chevalier, Pieter Smits, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Luc Wasungu, Divine Ediebah, Susan Veldhof, Yoshinobu Onuma	2016	121
10	Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? European Heart Journal ·Salvatore Brugaletta, Jung Ho Heo, Héctor M. García‐García, Vasim Farooq, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Pieter C. Smits, Jacques Koolen, Dougal McClean, Cécile Dorange, Susan Veldhof, Richard Rapoza, Yoshinobu Onuma, Nico Bruining, John A. Ormiston, Patrick W. Serruys	2012	108
11	Clinical and Angiographic Results With the Next-Generation Resolute Stent System JACC: Cardiovascular Interventions ·Ian T. Meredith, Stephen G. Worthley, Robert Whitbourn, D. Walters, Dougal McClean, M. Horrigan, Jeffrey J. Popma, Donald E. Cutlip, Ann DePaoli, Manuela Negoita, Peter J. Fitzgerald	2009	103
12	Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque? Atherosclerosis ·Salvatore Brugaletta, Maria Radu, Héctor M. García‐García, Jung Ho Heo, Vasim Farooq, Chrysafios Girasis, Robert‐Jan van Geuns, Leif Thuesen, Dougal McClean, Bernard Chevalier, Stephan Windecker, Jacques Koolen, Richard Rapoza, Karine Miquel‐Hébert, John A. Ormiston, Patrick W. Serruys	2011	102
13	Comparison of in vivo acute stent recoil between the bioresorbable everolimus‐eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus‐eluting stent Catheterization and Cardiovascular Interventions ·Yoshinobu Onuma, Patrick W. Serruys, J.A. Fernández Gómez, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Peter Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Héctor M. García‐García, John A. Ormiston, (unknown)	2011	95
14	Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold JACC: Cardiovascular Interventions ·Yoshinobu Onuma, Patrick W. Serruys, Takashi Muramatsu, Shimpei Nakatani, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Evald Høj Christiansen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Héctor M. García‐García, Susan Veldhof, Richard Rapoza, John A. Ormiston	2014	89
15	A Comparison of the Conformability of Everolimus-Eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents JACC: Cardiovascular Interventions ·Josep Gómez‐Lara, Héctor M. García‐García, Yoshinobu Onuma, Scot Garg, Evelyn Regar, Bernard De Bruyne, Stefan Windecker, Dougal McClean, Leif Thuesen, Dariusz Dudek, Jacques Koolen, Robert Whitbourn, Pieter C. Smits, Bernard Chevalier, Cécile Dorange, Susan Veldhof, Marie-Angèle Morel, Ton de Vries, John A. Ormiston, Patrick W. Serruys	2010	81
16	Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography JACC: Cardiovascular Interventions ·Josep Gómez‐Lara, Maria Radu, Salvatore Brugaletta, Vasim Farooq, Roberto Diletti, Yoshinobu Onuma, Stephan Windecker, Leif Thuesen, Dougal McClean, Jacques Koolen, Robert Whitbourn, Dariusz Dudek, Pieter C. Smits, Evelyn Regar, Susan Veldhof, Richard Rapoza, John A. Ormiston, Héctor M. García‐García, Patrick W. Serruys	2011	68
17	Six-Month Clinical and Angiographic Results of a Dedicated Drug-Eluting Stent for the Treatment of Coronary Bifurcation Narrowings The American Journal of Cardiology ·Eberhard Grube, Lutz Buellesfeld, Franz‐Josef Neumann, Stefan Verheye, Alexandre Abizaid, Dougal McClean, Ralf Mueller, Alexandra J. Lansky, Roxana Mehran, Ricardo A. Costa, Ulrich Gerckens, Brett Trauthen, Peter J. Fitzgerald	2007	61
18	Head-to-Head Comparison of the Neointimal Response Between Metallic and Bioresorbable Everolimus-Eluting Scaffolds Using Optical Coherence Tomography JACC: Cardiovascular Interventions ·Josep Gómez‐Lara, Salvatore Brugaletta, Vasim Farooq, Yoshinobu Onuma, Roberto Diletti, Stephan Windecker, Leif Thuesen, Dougal McClean, Jacques Koolen, Robert Whitbourn, Dariusz Dudek, Pieter C. Smits, Bernard Chevalier, Evelyn Regar, Susan Veldhof, Richard Rapoza, John A. Ormiston, Héctor M. García‐García, Patrick W. Serruys	2011	55
19	Angiographic Geometric Changes of the Lumen Arterial Wall After Bioresorbable Vascular Scaffolds and Metallic Platform Stents at 1-Year Follow-Up JACC: Cardiovascular Interventions ·Josep Gómez‐Lara, Salvatore Brugaletta, Vasim Farooq, Robert‐Jan van Geuns, Bernard De Bruyne, Stephan Windecker, Dougal McClean, Leif Thuesen, Dariusz Dudek, Jacques Koolen, Robert Whitbourn, Pieter C. Smits, Bernard Chevalier, Marie‐Angèle Morel, Cécile Dorange, Susan Veldhof, Richard Rapoza, Héctor M. García‐García, John A. Ormiston, Patrick W. Serruys	2011	39
20	Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data EuroIntervention ·Christos V. Bourantas, Patrick W. Serruys, Shimpei Nakatani, Yao‐Jun Zhang, Vasim Farooq, Roberto Diletti, Jurgen Ligthart, Alexander Sheehy, Robert‐Jan van Geuns, Dougal McClean, Bernard Chevalier, Stephan Windecker, Jacques Koolen, John A. Ormiston, Robert Whitbourn, Richard Rapoza, Susan Veldhof, Yoshinobu Onuma, Héctor M. García‐García	2015	37

About Dougal McClean

Dougal McClean is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Neurology, having authored 51 papers that have together received 3.2k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (40 papers), Cardiac Imaging and Diagnostics (6 papers), Cardiac Valve Diseases and Treatments (5 papers), Acute Myocardial Infarction Research (4 papers), Peripheral Artery Disease Management (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Disaster Response and Management (1 paper) and Vascular Procedures and Complications (1 paper). The work is most often cited by research in Surgery (2.6k citations), Cardiology and Cardiovascular Medicine (809 citations), Pulmonary and Respiratory Medicine (724 citations), Biomaterials (201 citations) and Radiology, Nuclear Medicine and Imaging (312 citations). Dougal McClean has collaborated with scholars based in New Zealand, Netherlands and Australia. Frequent co-authors include Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Stephan Windecker, Bernard Chevalier, Jacques Koolen, Robert Whitbourn, John A. Ormiston, Héctor M. García‐García and Susan Veldhof. Their work appears in journals such as EuroIntervention, Journal of the American College of Cardiology, JACC: Cardiovascular Interventions, Circulation Cardiovascular Interventions and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Dougal McClean

Impact in

Papers in i

In The Last Decade

Dougal McClean

Dougal McClean's Hit Papers

Peers

Countries citing papers authored by Dougal McClean

Fields of papers citing papers by Dougal McClean

All Works

About Dougal McClean

Explore authors with similar magnitude of impact

Papers in